MitoRx Therapeutics
PrivateLast Round
Early Funding
Nov 17, 2025
Total Funding Raised
$12.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MitoRx Therapeutics is a biotechnology company developing innovative small molecule mitochondrial metabolic modulators for weight loss and metabolic disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoRx Therapeutics Comparables
Compare MitoRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NRG Therapeutics | 87% | |
| Mitondra Therapeutics | 83% | |
| Pretzel Therapeutics | 83% |
MitoRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 17, 2025 | ||||
| Seed | Dec 13, 2023 | ||||
| Seed | Apr 25, 2022 |
MitoRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | Early Funding |
| Longevitytech.fund | Early Funding, Seed |
| UK Innovation & Science Seed Fund | Early Funding, Seed |
| Empirical Ventures | Early Funding |
| Wren Capital | Early Funding, Seed |
| Oxford Technology | Early Funding, Seed |
| Science Angels Syndicate | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 52% MoM.
- Jul 28, 2026
Monthly visitors increased 31% MoM, reaching 2.1K.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
MitoRx Therapeutics Limited attended event 62nd EASD Annual Meeting 2026 on Sep 16th '26.
- hiresSep 15, 2026
MitoRx Therapeutics Limited hired Mads as Clinical & Scientific Advisory Board on Sep 15th '26.
- hiresSep 15, 2026
MitoRx Therapeutics Limited hired Arne as Clinical & Scientific Advisory Board on Sep 15th '26.
- hiresSep 15, 2026
MitoRx Therapeutics Limited hired Rie as Clinical & Scientific Advisory Board on Sep 15th '26.
- hiresSep 15, 2026
MitoRx Therapeutics Limited hired Sven as Clinical & Scientific Advisory Board on Sep 15th '26.
MitoRx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MitoRx Therapeutics's valuation, stock price, and market status.
Is MitoRx Therapeutics a public or private company?
MitoRx Therapeutics is a private company.
What is the current stock price of MitoRx Therapeutics?
MitoRx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is MitoRx Therapeutics worth (valuation)?
Valuation information for MitoRx Therapeutics is not publicly available.
Can I buy MitoRx Therapeutics stock?
MitoRx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MitoRx Therapeutics's last funding round?
MitoRx Therapeutics's most recent funding round was pre-Series A on November 17, 2025.
Who are the main investors in MitoRx Therapeutics?
Key investors in MitoRx Therapeutics include Oshen Holdings SA.
Will MitoRx Therapeutics IPO soon?
No public IPO plans have been announced for MitoRx Therapeutics.
How can I track MitoRx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MitoRx Therapeutics's secondary market activity and sign up for updates.